The Evaluation of 68Ga-Citrate PET/CT Imaging for Dihydroartemisinin in the Treatment of Rheumatoid Arthritis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s11307-020-01534-4.pdf
Reference23 articles.
1. Chaudhari K, Rizvi S, Syed BA (2016) Rheumatoid arthritis: current and future trends. Nat Rev Drug Discov 15(5):305–306
2. Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1316–1322
3. Brown PM, Isaacs JD (2014) Rheumatoid arthritis: from palliation to remission in two decades. Clin Med (Lond) 14(Suppl 6):s50–s55
4. Cheong DHJ, Tan DWS, Wong FWS, Tran T (2020) Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases. Pharmacol Res 158:104901
5. Zhang Y, He W, Du Y et al (2020) Dimeric artesunate phospholipid-conjugated liposomes as promising anti-inflammatory therapy for rheumatoid arthritis. Int J Pharm 579:119178
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Gallium-68 Labelled Radiopharmaceuticals for Imaging Inflammatory Disorders;Seminars in Nuclear Medicine;2023-03
2. Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms;Acta Pharmacologica Sinica;2022-09-01
3. Dihydroarteannuin Ameliorates Collagen-Induced Arthritis Via Inhibiting B Cell Activation by Activating the FcγRIIb/Lyn/SHP-1 Pathway;Frontiers in Pharmacology;2022-05-03
4. Dihydroartemisinin inhibits IL-6-induced epithelial–mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway;Journal of International Medical Research;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3